Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


20.02.2017

1 Biol Psychiatry
1 J Clin Psychopharmacol
1 Mol Psychiatry
1 Neuropsychopharmacology
1 Pharmacopsychiatry
12 Psychiatry Res
4 Psychol Med
8 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biol Psychiatry

  1. CORLETT PR
    I Predict, Therefore I Am: Perturbed Predictive Coding Under Ketamine and in Schizophrenia.
    Biol Psychiatry. 2017;81:465-466.
    PubMed     Text format    


    J Clin Psychopharmacol

  2. GLICK ID, Davis JM, Zamora D, Ballon J, et al
    Should Antipsychotic Medications for Schizophrenia Be Given for a Lifetime?: A Naturalistic, Long-Term Follow-Up Study.
    J Clin Psychopharmacol. 2017 Feb 13. doi: 10.1097/JCP.0000000000000680.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  3. COLLSTE K, Plaven-Sigray P, Fatouros-Bergman H, Victorsson P, et al
    Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28.
    Mol Psychiatry. 2017 Feb 14. doi: 10.1038/mp.2016.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  4. ZHEUTLIN AB, Jeffries CD, Perkins DO, Chung Y, et al
    The Role of microRNA Expression in Cortical Development During Conversion to Psychosis.
    Neuropsychopharmacology. 2017 Feb 10. doi: 10.1038/npp.2017.
    PubMed     Text format     Abstract available


    Pharmacopsychiatry

  5. NOVICK D, Montgomery W, Treuer T, Moneta MV, et al
    Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative Symptoms.
    Pharmacopsychiatry. 2017 Feb 16. doi: 10.1055/s-0042-112818.
    PubMed     Text format     Abstract available


    Psychiatry Res

  6. GROVER S, Dua D, Chakrabarti S, Avasthi A, et al
    Obsessive Compulsive Symptoms/disorder in patients with schizophrenia: Prevalence, relationship with other symptom dimensions and impact on functioning.
    Psychiatry Res. 2017;250:277-284.
    PubMed     Text format     Abstract available

  7. PRIKKEN M, van der Weiden A, Renes RA, Koevoets MG, et al
    Abnormal agency experiences in schizophrenia patients: Examining the role of psychotic symptoms and familial risk.
    Psychiatry Res. 2016;250:270-276.
    PubMed     Text format     Abstract available

  8. JANSEN JE, Lysaker PH, Trauelsen AM, Luther L, et al
    Metacognitive mastery in persons with first-episode psychosis and their caregivers: Implications for timely help-seeking and caregiver experiences. Brief report.
    Psychiatry Res. 2017;251:54-57.
    PubMed     Text format     Abstract available

  9. MALHERBE PJ, Karayiorgou M, Ehlers R, Roos JL, et al
    Increased risk of suicide in schizophrenia patients with linkage to chromosome 13q.
    Psychiatry Res. 2017;251:34-35.
    PubMed     Text format     Abstract available

  10. GERRETSEN P, Takeuchi H, Ozzoude M, Graff-Guerrero A, et al
    Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: An antipsychotic dose reduction study.
    Psychiatry Res. 2017;251:20-25.
    PubMed     Text format     Abstract available

  11. VAN DEN NOORT M, Perriard B, Lim S, Bosch P, et al
    Why are self-rating results in patients with schizophrenia often unreliable?
    Psychiatry Res. 2017;251:76-77.
    PubMed     Text format    

  12. BILGI MM, Taspinar S, Aksoy B, Oguz K, et al
    The relationship between childhood trauma, emotion recognition, and irritability in schizophrenia patients.
    Psychiatry Res. 2017;251:90-96.
    PubMed     Text format     Abstract available

  13. HU TM, Hsu SH, Tsai SM, Cheng MC, et al
    DNA methylation analysis of the EGR3 gene in patients of schizophrenia.
    Psychiatry Res. 2017;251:115-117.
    PubMed     Text format     Abstract available

  14. BECHI M, Bosia M, Spangaro M, Buonocore M, et al
    Exploring functioning in schizophrenia: Predictors of functional capacity and real-world behaviour.
    Psychiatry Res. 2017;251:118-124.
    PubMed     Text format     Abstract available

  15. LI Q, Du X, Zhang Y, Yin G, et al
    The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia.
    Psychiatry Res. 2016;251:131-136.
    PubMed     Text format     Abstract available

  16. FRANCIS MM, Hummer TA, Leonhardt BL, Vohs JL, et al
    Association of medial prefrontal resting state functional connectivity and metacognitive capacity in early phase psychosis.
    Psychiatry Res. 2017;262:8-14.
    PubMed     Text format     Abstract available

  17. GOGHARI VM
    Personality dimensions in schizophrenia: A family study.
    Psychiatry Res. 2017;251:162-167.
    PubMed     Text format     Abstract available


    Psychol Med

  18. XU Y, Qin W, Zhuo C, Xu L, et al
    Selective functional disconnection of the orbitofrontal subregions in schizophrenia.
    Psychol Med. 2017 Feb 10:1-10. doi: 10.1017/S0033291717000101.
    PubMed     Text format     Abstract available

  19. RHINDRESS K, Robinson DG, Gallego JA, Wellington R, et al
    Hippocampal subregion volume changes associated with antipsychotic treatment in first-episode psychosis.
    Psychol Med. 2017 Feb 14:1-13. doi: 10.1017/S0033291717000137.
    PubMed     Text format     Abstract available

  20. GRONHOLM PC, Thornicroft G, Laurens KR, Evans-Lacko S, et al
    Mental health-related stigma and pathways to care for people at risk of psychotic disorders or experiencing first-episode psychosis: a systematic review.
    Psychol Med. 2017 Feb 15:1-13. doi: 10.1017/S0033291717000344.
    PubMed     Text format     Abstract available

  21. FIRTH J, Stubbs B, Sarris J, Rosenbaum S, et al
    The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis.
    Psychol Med. 2017 Feb 16:1-13. doi: 10.1017/S0033291717000022.
    PubMed     Text format     Abstract available


    Schizophr Res

  22. LY D, DeLisi LE
    Can antibiotics cause a psychosis?: Case report and review of the literature.
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30054.
    PubMed     Text format     Abstract available

  23. MEZQUIDA G, Cabrera B, Bioque M, Amoretti S, et al
    The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30060.
    PubMed     Text format     Abstract available

  24. BRIEND F, Leroux E, Delcroix N, Razafimandimby A, et al
    Impact of rTMS on functional connectivity within the language network in schizophrenia patients with auditory hallucinations.
    Schizophr Res. 2017 Feb 8. pii: S0920-9964(17)30067.
    PubMed     Text format     Abstract available

  25. ROBERTS RC
    Postmortem studies on mitochondria in schizophrenia.
    Schizophr Res. 2017 Feb 9. pii: S0920-9964(17)30070.
    PubMed     Text format     Abstract available

  26. GEISER E, Retsa C, Knebel JF, Ferrari C, et al
    The coupling of low-level auditory dysfunction and oxidative stress in psychosis patients.
    Schizophr Res. 2017 Feb 9. pii: S0920-9964(17)30073.
    PubMed     Text format     Abstract available

  27. OESTREICH LK, Lyall AE, Pasternak O, Kikinis Z, et al
    Characterizing white matter changes in chronic schizophrenia: A free-water imaging multi-site study.
    Schizophr Res. 2017 Feb 10. pii: S0920-9964(17)30077.
    PubMed     Text format     Abstract available

  28. LOPEZ-GIMENEZ JF, de la Fuente Revenga M, Ruso-Julve F, Saunders JM, et al
    Validation of schizophrenia gene expression profile in a preclinical model of maternal infection during pregnancy.
    Schizophr Res. 2017 Feb 12. pii: S0920-9964(17)30076.
    PubMed     Text format    

  29. MUELLER DR, Khalesi Z, Benzing V, Castiglione CI, et al
    Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?
    Schizophr Res. 2017 Feb 6. pii: S0920-9964(17)30050.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: